Cargando…

Late recovery of renal failure after autologous haematopoietic stem cell transplantation for multiple myeloma: a report of two cases

Acute renal failure is a frequent feature in patients with multiple myeloma (MM). MM-related renal insufficiency may improve after autologous haematopoietic stem cell transplantation (autoHSCT) even in patients initially requiring dialysis. Herein, we report on two unusual cases of late improvement...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bigé, Naïke, Guéry, Bruno, Delarue, Richard, Noël, Laure-Hélène, Fakhouri, Fadi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2009
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421199/ https://www.ncbi.nlm.nih.gov/pubmed/25984001 http://dx.doi.org/10.1093/ndtplus/sfp013

Ejemplares similares

Urinary tract obstruction due to extramedullary plasmacytoma: report of two cases
por: Bigé, Naïke, et al.
Publicado: (2009)

Autologous haematopoietic stem cell transplantation for neurological diseases
por: Burman, Joachim, et al.
Publicado: (2018)

Autologous Stem Cell Transplantation in Multiple Myeloma with Renal Failure: Friend or Foe?
por: Zhong, Hongfei, et al.
Publicado: (2019)

The Glasgow Prognostic Score at Diagnosis Is a Predictor of Clinical Outcome in Patients with Multiple Myeloma Undergoing Autologous Haematopoietic Stem Cell Transplantation
por: Witte, Hanno M., et al.
Publicado: (2020)

The current standing of autologous haematopoietic stem cell transplantation for the treatment of multiple sclerosis
por: Willison, A. G., et al.
Publicado: (2022)

Second autologous haematopoietic stem cell transplantation in systemic sclerosis—a case report
por: van Rhijn-Brouwer, Femke C C, et al.
Publicado: (2019)

Autologous haematopoietic stem cell transplantation for refractory stiff-person syndrome: the UK experience
por: Kass-Iliyya, Lewis, et al.
Publicado: (2020)

Autologous Haematopoietic Stem Cell Transplantation and Systemic Sclerosis: Focus on Interstitial Lung Disease
por: Bagnato, Gianluca, et al.
Publicado: (2022)

Correction to: The current standing of autologous haematopoietic stem cell transplantation for the treatment of multiple sclerosis
por: Willison, A. G., et al.
Publicado: (2022)

Abnormal body composition is a predictor of adverse outcomes after autologous haematopoietic cell transplantation
por: Armenian, Saro H., et al.
Publicado: (2020)

Autologous haematopoietic stem cell transplantation for multiple sclerosis: a position paper and registry outline
por: Bayas, Antonios, et al.
Publicado: (2023)

Sequential, Autologous Hematopoietic Stem Cell Transplant Followed by Renal Transplant in Multiple Myeloma
por: Bhowmik, D., et al.
Publicado: (2017)

Chronic inflammatory demyelinating polyradiculoneuropathy occurring after autologous haematopoietic stem cell transplantation for multiple sclerosis
por: Simonsen, Cecilia Smith, et al.
Publicado: (2016)

Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing–remitting multiple sclerosis: an observational study
por: Zhukovsky, Christina, et al.
Publicado: (2021)

Autologous haematopoietic stem cell transplantation versus low‐dose immunosuppression in secondary–progressive multiple sclerosis
por: Mariottini, Alice, et al.
Publicado: (2022)

Trajectory of lung function to pleuroparenchymal fibroelastosis late after haematopoietic stem-cell transplantation
por: Barisione, Giovanni, et al.
Publicado: (2019)

Is it feasible to conduct a randomised controlled trial of pretransplant exercise (prehabilitation) for patients with multiple myeloma awaiting autologous haematopoietic stem cell transplantation? Protocol for the PREeMPT study
por: Keen, Carol, et al.
Publicado: (2018)

Autologous Haematopoietic Stem Cell Transplantation in Multiple Sclerosis: a Review of Current Literature and Future Directions for Transplant Haematologists and Oncologists
por: Das, Joyutpal, et al.
Publicado: (2019)

Autologous transplant for myeloma: when the old meets the new
por: Gay, Francesca, et al.
Publicado: (2017)

Autologous Stem Cell Transplantation for Myeloma: Cytoreduction or an Immunotherapy?
por: Minnie, Simone A., et al.
Publicado: (2021)

Inhibitory KIR–HLA receptor–ligand mismatch in autologous haematopoietic stem cell transplantation for solid tumour and lymphoma
por: Leung, W, et al.
Publicado: (2007)

PB2193: IS HYPERHYDRATION NECESSARY FOR HIGH DOSE MELPHALAN CONDITIONING REGIMEN IN AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION?
por: Mora Argumánez, M., et al.
Publicado: (2022)

Cerebrospinal fluid cytokines after autologous haematopoietic stem cell transplantation and intrathecal rituximab treatment for multiple sclerosis
por: Burman, Joachim, et al.
Publicado: (2023)

CXCR2 modulates bone marrow vascular repair and haematopoietic recovery post‐transplant
por: Hale, Sarah J. M., et al.
Publicado: (2015)

Standardizing haematopoietic cell transplants in China
por: Gale, Robert Peter
Publicado: (2018)

Long-Term Suppression of Circulating Proinflammatory Cytokines in Multiple Sclerosis Patients Following Autologous Haematopoietic Stem Cell Transplantation
por: Hendrawan, Kevin, et al.
Publicado: (2022)

Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with ‘aggressive’ multiple sclerosis
por: Das, J, et al.
Publicado: (2021)

Changes on chest HRCT in systemic sclerosis-related interstitial lung disease after autologous haematopoietic stem cell transplantation
por: Pugnet, Grégory, et al.
Publicado: (2022)

Anti-thymocyte globulin exposure in patients with diffuse cutaneous systemic sclerosis undergoing autologous haematopoietic stem cell transplantation
por: Chiu, Yu-Hsiang, et al.
Publicado: (2023)

Current status of autologous stem cell transplantation for multiple myeloma
por: Al Hamed, Rama, et al.
Publicado: (2019)

Haematopoietic Stem Cell Transplant for Norovirus-Induced Intestinal Failure in X-linked Agammaglobulinemia
por: Shillitoe, Ben M. J., et al.
Publicado: (2021)

The impact of repeated autologous infusion of haematopoietic stem cells in patients with liver insufficiency
por: Zekri, Abdel-Rahman N., et al.
Publicado: (2015)

Fully Immunocompetent CD8+ T Lymphocytes Are Present in Autologous Haematopoietic Stem Cell Transplantation Recipients Despite an Ineffectual T-Helper Response
por: Bandera, Alessandra, et al.
Publicado: (2008)

A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper
por: Saccardi, R, et al.
Publicado: (2012)

Supplementation with Oral Vitamin C Prior to and during Myeloablative Chemotherapy and Autologous Haematopoietic Stem Cell Transplantation: A Pilot Study
por: Carr, Anitra C., et al.
Publicado: (2022)

Outcomes after autologous hematopoietic cell transplantation in POEMS syndrome and comparison with multiple myeloma
por: Kansagra, Ankit, et al.
Publicado: (2022)

Haematopoietic stem cell transplantation as first-line treatment in myeloma: a global perspective of current concepts and future possibilities
por: Mactier, Catriona Elizabeth, et al.
Publicado: (2012)

Immune recovery and the risk of CMV/ EBV reactivation in children post allogeneic haematopoietic stem cell transplantation
por: Janeczko, Małgorzata, et al.
Publicado: (2016)

Autologous Haematopoietic Stem Cell Transplantation for Crohn’s Disease: A Retrospective Survey of Long-term Outcomes From the European Society for Blood and Marrow Transplantation
por: Brierley, Charlotte K, et al.
Publicado: (2018)

In Utero Haematopoietic Stem Cell Transplantation (IUHSCT)
por: Renda, Maria Concetta, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_fspdvnbf42a5sqcqefb8nir9q5